Analysis | Metabolite Name | Measured Value | Units | Group |
---|---|---|---|---|
HILIC POSITIVE ION MODE | 1-palmitoyl-GPE (16:0) | 0.5044 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPE (16:0) | 0.5348 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPE (16:0) | 0.5401 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPE (16:0) | 0.5509 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPE (16:0) | 0.5528 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPE (16:0) | 0.5672 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPE (16:0) | 0.5711 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPE (16:0) | 0.6157 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPE (16:0) | 0.6244 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPE (16:0) | 0.6376 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPE (16:0) | 0.6606 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPE (16:0) | 0.6681 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPE (16:0) | 0.6689 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPE (16:0) | 0.6847 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPE (16:0) | 0.6852 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPE (16:0) | 0.6864 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPE (16:0) | 0.7097 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPE (16:0) | 0.7172 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPE (16:0) | 0.7251 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPE (16:0) | 0.7455 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPE (16:0) | 0.7627 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPE (16:0) | 0.7668 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPE (16:0) | 0.7945 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPE (16:0) | 0.8000 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPE (16:0) | 0.8052 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPE (16:0) | 0.8111 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPE (16:0) | 0.8136 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPE (16:0) | 0.8206 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPE (16:0) | 0.8420 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPE (16:0) | 0.8441 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPE (16:0) | 0.8523 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPE (16:0) | 0.8546 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPE (16:0) | 0.8745 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPE (16:0) | 0.8787 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPE (16:0) | 0.8795 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPE (16:0) | 0.8872 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPE (16:0) | 0.8946 | Peak area | Normal |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPE (16:0) | 0.8982 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPE (16:0) | 0.9073 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPE (16:0) | 0.9109 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPE (16:0) | 0.9202 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPE (16:0) | 0.9255 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPE (16:0) | 0.9297 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPE (16:0) | 0.9315 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPE (16:0) | 0.9399 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPE (16:0) | 0.9521 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPE (16:0) | 0.9602 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPE (16:0) | 0.9697 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPE (16:0) | 0.9863 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPE (16:0) | 0.9884 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPE (16:0) | 0.9937 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPE (16:0) | 0.9984 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPE (16:0) | 0.9991 | Peak area | Normal |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPE (16:0) | 1.0009 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPE (16:0) | 1.0042 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPE (16:0) | 1.0046 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPE (16:0) | 1.0147 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPE (16:0) | 1.0192 | Peak area | Normal |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPE (16:0) | 1.0207 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPE (16:0) | 1.0271 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPE (16:0) | 1.0280 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPE (16:0) | 1.0363 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPE (16:0) | 1.0528 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPE (16:0) | 1.0799 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPE (16:0) | 1.0906 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPE (16:0) | 1.0958 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPE (16:0) | 1.1250 | Peak area | Normal |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPE (16:0) | 1.1258 | Peak area | Normal |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPE (16:0) | 1.1261 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPE (16:0) | 1.1322 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPE (16:0) | 1.1335 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPE (16:0) | 1.1392 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPE (16:0) | 1.1455 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPE (16:0) | 1.2035 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPE (16:0) | 1.2121 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPE (16:0) | 1.2274 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPE (16:0) | 1.2420 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPE (16:0) | 1.2547 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPE (16:0) | 1.2555 | Peak area | Normal |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPE (16:0) | 1.2597 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPE (16:0) | 1.2738 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPE (16:0) | 1.2749 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPE (16:0) | 1.2949 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPE (16:0) | 1.2978 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPE (16:0) | 1.3479 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPE (16:0) | 1.3907 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPE (16:0) | 1.4114 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPE (16:0) | 1.4419 | Peak area | Normal |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPE (16:0) | 1.4479 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPE (16:0) | 1.4776 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPE (16:0) | 1.4779 | Peak area | Normal |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPE (16:0) | 1.5150 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPE (16:0) | 1.5349 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPE (16:0) | 1.5369 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPE (16:0) | 1.5447 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPE (16:0) | 1.5923 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPE (16:0) | 1.6293 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPE (16:0) | 1.7001 | Peak area | Normal |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPE (16:0) | 1.7379 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPE (16:0) | 1.7915 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPE (16:0) | 1.8653 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPE (16:0) | 1.9246 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPE (16:0) | 1.9979 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPE (16:0) | 2.3828 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPE (16:0) | 2.3958 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | 1-palmitoyl-GPE (16:0) | 3.0120 | Peak area | Diabetic Neuropathy |